EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Microbiome and metabolomics reveal the effect of gut microbiota on liver regeneration of fatty liver disease

Yiqing Hu, Xiaoyi Hu, Li Jiang, Jia Luo, Jiacheng Huang, Yaohan Sun, Yinbiao Qiao, Hao Wu, Shijie Zhou, Haoyu Li, Jianhui Li, Lin Zhou und 1 weitere

eBioMedicine · 2025-01 · 111 · 105482

DOI: 10.1016/j.ebiom.2024.105482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eBioMedicine, 2025-01. Verfasst von Yiqing Hu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangz…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver Regeneration, Metabolomics, Fatty Liver. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Metabolic dysfunction-associated fatty liver disease (MAFLD) is associated with impaired regenerative capacity and poor postoperative prognosis following hepatectomy. Previous research has highlighted the importance of the gut-liver axis in the physiological and pathological processes of the liver. However, the contribution of gut bacteria to the regeneration of livers with MAFLD and its metabolic regulatory mechanisms remain elusive. METHODS: Partial hepatectomy (PHx) was performed on C57Bl/6J mice fed with high-fat diet (HFD) for 12 weeks. Pathological examination, immunohistochemistry, and qRT-PCR analysis were performed to assess the severity of steatosis and proliferative potential. The gut microbiome was examined by 16S rRNA gene sequencing and shotgun metagenomics, whereas liver metabolomics was analysed via untargeted and targeted metabolomics using liquid chromatography-tandem mass spectrometry (LC-MS). FINDINGS: HFD-induced hepatic steatosis in mice led to impaired liver regeneration following PHx. The gut microbiota and liver metabolites were altered along with the liver regeneration process. Longitudinal time-series analysis revealed dynamic alterations in these data, whereas correlation analysis screened out bacterial candidates that potentially influence liver regeneration in MAFLD by modulating metabolic pathways. Among these bacteria, the dominant bacterium Akkermansia was selected for subsequent investigation. MAFLD mice gavaged with Akkermansia muciniphila (A. muciniphila) exhibited reduced liver lipid accumulation and accelerated liver regeneration, possibly through the regulation of the tricarboxylic acid (TCA) cycle. INTERPRETATION: These data demonstrated the interplay between the gut microbiome, liver metabolomics, and liver regeneration in mice with MAFLD. A. muciniphila has the potential to serve as a clinical intervention agent to accelerate postoperative recovery in MAFLD. FUNDING: This work was supported by the Research Project of Jinan Microecological Biomedicine Shandong Laboratory [JNL-2022008B]; the Zhejiang Provincial Natural Science Foundation of China [LZ21H180001]; the Fundamental Research Funds for the Central Universities [No. 2022ZFJH003].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLiver RegenerationMetabolomicsFatty LiverMetabolomeNon-alcoholic Fatty Liver DiseaseAnimalsMiceDiet, High-FatMaleDisease Models, AnimalLiverRNA, Ribosomal, 16SMice, Inbred C57BLMetagenomicsHepatectomy

Stichwörter der Autor:innen

A. muciniphilaGut microbiotaLiver regenerationMetabolic associated fatty liver diseaseMetabolomics

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China; NHC Key Laboratory of Combined Multi-Organ Transpl…
  • Laboratory of Animal Research Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
  • The Affiliated Hospital of Kunming University of Science and Technology, The First People' Hospital of Yunnan Province, Kunming, 650500, China.
  • NHC Key Laboratory of Combined Multi-Organ Transplantation, Hangzhou, 310003, China.
  • General Surgery, Cancer Center, Department of Colorectal Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, 310014, China.
  • Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Zhejiang Shuren University School of Medicine, Hangzhou, 310015, China.

Zitieren

APA

Hu, Y., Hu, X., Jiang, L., Luo, J., Huang, J., Sun, Y., Qiao, Y., Wu, H., Zhou, S., Li, H., Li, J., Zhou, L., & Zheng, S. (2025). Microbiome and metabolomics reveal the effect of gut microbiota on liver regeneration of fatty liver disease. eBioMedicine, 111, 105482. https://doi.org/10.1016/j.ebiom.2024.105482

Vancouver

Hu Y, Hu X, Jiang L, Luo J, Huang J, Sun Y, et al. Microbiome and metabolomics reveal the effect of gut microbiota on liver regeneration of fatty liver disease. eBioMedicine. 2025;111:105482. doi:10.1016/j.ebiom.2024.105482

BibTeX
@article{Hu2025,
  author = {Hu, Yiqing and Hu, Xiaoyi and Jiang, Li and Luo, Jia and Huang, Jiacheng and Sun, Yaohan and Qiao, Yinbiao and Wu, Hao and Zhou, Shijie and Li, Haoyu and Li, Jianhui and Zhou, Lin and Zheng, Shusen},
  title = {Microbiome and metabolomics reveal the effect of gut microbiota on liver regeneration of fatty liver disease},
  journal = {eBioMedicine},
  year = {2025},
  volume = {111},
  pages = {105482},
  doi = {10.1016/j.ebiom.2024.105482}
}
Kostenlos starten →